Location History:
- Yongin-si, KR (2018)
- Suwon-si, KR (2017 - 2020)
- Gyeonggi-do, KR (2020)
Company Filing History:
Years Active: 2017-2020
Title: The Innovative Journey of Chang Mo Son
Introduction
Chang Mo Son, an esteemed inventor based in Gyeonggi-do, South Korea, has made significant strides in the field of pharmaceuticals, particularly in the area of metabolic disease treatment. With a remarkable total of four patents, his contributions reflect a deep understanding of biochemical interactions and a dedication to improving health outcomes.
Latest Patents
Among his latest patents, two noteworthy innovations stand out. The first is a **Composite preparation**, which includes a novel 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative. This pharmaceutical composition is designed for preventing and treating metabolic diseases, demonstrating a remarkable blood sugar-reducing effect in various diabetic animal models. The composition can address a wide range of metabolic conditions such as obesity, Type I and Type II diabetes, and symptoms of insulin resistance.
The second patent pertains to a **Cyclohexene derivative**, focusing on a preparation method and a pharmaceutical composition that utilizes this derivative as an active ingredient. This invention not only enhances the intracellular activity of cyclic adenosine monophosphate (cAMP) but also induces the release of glucagon-like peptide-1 (GLP-1), facilitating weight loss and hypoglycemic effects. It holds potential for treating several metabolic diseases, including obesity and various types of diabetes.
Career Highlights
Chang Mo Son's professional journey has been marked by his impactful work with Hyundai Pharm Co., Ltd., where he applies his innovative ideas to create pharmaceutical compositions aimed at improving patient outcomes. His expertise in developing compounds for metabolic diseases showcases his commitment to advancing healthcare.
Collaborations
Throughout his career, Chang has collaborated with talented individuals such as Jin Wook Yang and Han Kyu Lee. These partnerships reflect a collaborative spirit in research and innovation, allowing for a rich exchange of ideas and expertise within the pharmaceutical field.
Conclusion
Chang Mo Son continues to be a leading figure in pharmaceutical innovation, especially in the management of metabolic diseases. His groundbreaking patents offer promising advancements in treatment options, revealing the potential to significantly improve the quality of life for patients suffering from these conditions. The work of Chang Mo Son exemplifies the vital role of inventors in shaping the future of medicine and healthcare.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.